União Europeia - esloveno - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfom, mantle cell - antineoplastična sredstva - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

União Europeia - esloveno - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotična sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - venlafaksin - kapsula s podaljšanim sproščanjem, trda - venlafaksin 75 mg / 1 kapsula - venlafaksin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - venlafaksin - kapsula s podaljšanim sproščanjem, trda - venlafaksin 150 mg / 1 kapsula - venlafaksin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - venlafaksin - kapsula s podaljšanim sproščanjem, trda - venlafaksin 75 mg / 1 kapsula - venlafaksin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - venlafaksin - kapsula s podaljšanim sproščanjem, trda - venlafaksin 150 mg / 1 kapsula - venlafaksin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 60 mg / 1 kapsula - duloksetin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - duloksetin - gastrorezistentna kapsula, trda - duloksetin 30 mg / 1 kapsula - duloksetin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - duloksetin - gastrorezistentna kapsula, trda - duloksetin 60 mg / 1 kapsula - duloksetin

Eslovênia - esloveno - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - duloksetin - gastrorezistentna kapsula, trda - duloksetin 30 mg / 1 kapsula - duloksetin